Literature DB >> 11181

Analysis of immunosuppression generated by the graft-versus-host reaction. II. Characterization of the suppression cell and its mechanism of action.

F L Shand.   

Abstract

Spleen cells from (CBA X C57/BL) F1 mice undergoing graft-versus-host (GVH) reaction induced by injection of parental cells 7-14 days previously are capable of suppressing an immune response by normal or primed F1 spleen cells to chicken erythrocytes and levan in vivo and sheep erythrocytes in vitro. The cells in these GVH spleens which were responsible for the suppression were sensitive to treatment with anti-0 serum, resistant to 900 rad irradiation in vivo and not retained by anti-immunoglobulin columns. Suppressor activity in vitro was present only in the non-adherent fraction of these GVH cell suspensions. Furthermore, the T-cell fraction, purified by affinity chromatography, suppressed the in vitro response of macrophage-depleted normal F1 cells to DNP-levan. Collectively, these observations imply that suppressor T cells generated by GVH reaction can affect B-cell functions directly without intermediary macrophage participation. Spleen cells from (CBA X C57/BL) F1 mice undergoing GVH reaction induced by C57/BL cells were depleted of their F1 content by treatment with anti-CBA alloantiserum. The suppressive activity of the residual donor component was still expressed against other F1 cells (AKR X C57/BL) which were H-2 compatible with the original host, but not against H-2-incompatible cells (DBA/1 X C57/BL) F1. However, the latter were suppressed in the presence of (CBA X C57/BL) F1 cells. Thus, interaction of donor T cells with F1 target cells containing those H-2 antigens towards which they are sensitized is mandatory for the subsequent manifestation of immunosuppressive activity. GVH cells suppressed the response of primed F1 cells in double Marbrook chambers when the two populations were separated were by a cell-impermeable membrane, provided the GVH suspension contained F1 cells to which donor T cells were sensitized. This suggests that soluble factors are involved in the mechanism of GVH-induced immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 11181      PMCID: PMC1445189     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Different Ly antigen phenotypes of in vitro induced helper and suppressor cells.

Authors:  M Feldmann; P C Beverley; M Dunkley; S Kontiainen
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

2.  Antibody synthesis by chicken spleen cells in vitro. I. Requirements of B cells at various stages after immunization for T cells, macrophages and antigen.

Authors:  G Evans; J Ivanyi
Journal:  Eur J Immunol       Date:  1975-11       Impact factor: 5.532

3.  Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo.

Authors:  F L Shand
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

4.  Graft-versus-host induced immunosuppression: depressed T cell helper function in vitro.

Authors:  R Elie; W S Lapp
Journal:  Cell Immunol       Date:  1976-01       Impact factor: 4.868

5.  Cytological estimation of the proportion of proliferating donor cells during graft-versus-host disease in F1 hybrid mice infected with parental spleen cells.

Authors:  M FOX
Journal:  Nature       Date:  1962-09-08       Impact factor: 49.962

6.  Lack of requirement for cell cooperation in the antibody response to DNP conjugated to levan.

Authors:  C Desaymard; M Feldmann
Journal:  Cell Immunol       Date:  1975-03       Impact factor: 4.868

7.  Cellular immunity in the mouse. IV. Altered thymic-dependent lymphocyte reactivity in the chronic graft vs host reaction and leukemia virus activation.

Authors:  S M Phillips; H Gleichmann; M S Hirsch; P Black; J P Merrill; R S Schwartz; C B Carpenter
Journal:  Cell Immunol       Date:  1975-01       Impact factor: 4.868

8.  Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.

Authors:  R McMaster; J G Levy
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

9.  Cell interactions in the immune response in vitro. V. Specific collaboration via complexes of antigen and thymus-derived cell immunoglobulin.

Authors:  M Feldmann
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

Review 10.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

View more
  8 in total

1.  The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro.

Authors:  F L Shand
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

2.  Prevention of oral tolerance induction to ovalbumin and enhanced antigen presentation during a graft-versus-host reaction in mice.

Authors:  S Strobel; A M Mowat; A Ferguson
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

3.  Modulation of intestinal and systemic immune responses to a fed protein antigen, in mice.

Authors:  S Strobel; A Ferguson
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

4.  Rabbit anti-EL4 serum. A reagent which discriminates between murine cytotoxic and suppressor cells.

Authors:  L Al-Sakkaf; A Cooke; L Heppel; P Hutchings; B Jones
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

5.  Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.

Authors:  E H Van Elven; A G Rolink; F V Veen; E Gleichmann
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

6.  Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host disease.

Authors:  A G Rolink; T Radaszkiewicz; S T Pals; W G van der Meer; E Gleichmann
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

Review 7.  Association of lpr gene with graft-vs.-host disease-like syndrome.

Authors:  A N Theofilopoulos; R S Balderas; Y Gozes; M T Aguado; L M Hang; P R Morrow; F J Dixon
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

8.  Graft-vs.-host-associated immune suppression is activated by recognition of allogeneic murine I-A antigens.

Authors:  G M Shearer; R B Levy
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.